Curtis Ruegg - Net Worth and Insider Trading
Curtis Ruegg Net Worth
The estimated net worth of Curtis Ruegg is at least $139,115 dollars as of 2024-09-20. Curtis Ruegg is the EVP, Technical Operations of Revance Therapeutics Inc and owns about 23,944 shares of Revance Therapeutics Inc (RVNC) stock worth over $139,115. Details can be seen in Curtis Ruegg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Curtis Ruegg has not made any transactions after 2016-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Curtis Ruegg
Curtis Ruegg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Curtis Ruegg owns 1 companies in total, including Revance Therapeutics Inc (RVNC) .
Click here to see the complete history of Curtis Ruegg’s form 4 insider trades.
Insider Ownership Summary of Curtis Ruegg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2016-06-13 | EVP R&D and Tech Operations |
Curtis Ruegg Latest Holdings Summary
Curtis Ruegg currently owns a total of 1 stock. Curtis Ruegg owns 23,944 shares of Revance Therapeutics Inc (RVNC) as of June 13, 2016, with a value of $139,115.
Latest Holdings of Curtis Ruegg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2016-06-13 | 23,944 | 5.81 | 139,115 |
Holding Weightings of Curtis Ruegg
Curtis Ruegg Form 4 Trading Tracker
According to the SEC Form 4 filings, Curtis Ruegg has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the sale of 1,000 shares on June 13, 2016, which brought Curtis Ruegg around $18,250.
Insider Trading History of Curtis Ruegg
- 1
Curtis Ruegg Trading Performance
Curtis Ruegg Ownership Network
Curtis Ruegg Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
Curtis Ruegg is the EVP R&D and Tech Operations of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, Curtis Ruegg made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 38,865 shares made by Tobin Schilke , and a net sale of 64,379 shares made by Dwight Moxie .
In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 297,646 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 267,646 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
Curtis Ruegg Mailing Address
Above is the net worth, insider trading, and ownership report for Curtis Ruegg. You might contact Curtis Ruegg via mailing address: 7555 Gateway Boulevard, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
